Cardiovascular medicines 2022. (Long Term Agreement valid until 31 Dec. 2022)

Download (615.74 KB)

1. The prices published reflect the price of the product

2. For budgeting purposes PAHO suggests Member States add an additional 15-25% to reflect the costs of shipping, insurance, 2.5% contribution to the SF capital account and the 1.75% PAHO fee

3. Questions should be directed to For further information on the PAHO Strategic Fund please visits